tirzepatide type 2 diabetes Read now: The SURPASS-EARLY trial found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, and waist size than intensified standard care. https://bit.ly/3RWnB8m Big update in pediatric diabetes

Damiescu, R., Efferth, T

Clinical experience shows that nausea intensity often decreases noticeably by week 2, with most patients reporting minimal or no nausea by week 34

(Both medications are also approved to reduce cardiovascular risk in people with known heart disease and either type 2 diabetes or obesity.) Semaglutide belongs to a category of prescription medications known as GLP-1s

Tirzepatide: Whats the Difference and How Do You Know Which Is Right for You

These adverse effects have led to numerous lawsuits against Novo Nordisk, alleging that the company failed to adequately warn users about the potential risks associated with Semaglutide